Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation
Yueh‐Chien Lin(Boston Children's Hospital), Timothy Hla(American Red Cross), Robert Flaumenhaft(Beth Israel Deaconess Medical Center), Garret A. FitzGerald(Translational Therapeutics (United States)), Samir M. Parikh(Beth Israel Deaconess Medical Center), David Zurakowski(Boston Children's Hospital), Takahiro Seno(Boston Children's Hospital), Andrew Kuo(Boston Children's Hospital), Steven Swendeman(Boston Children's Hospital), Zeynep H. Gümüş(Icahn School of Medicine at Mount Sinai), Avishek Ghosh(Boston Children's Hospital), Alan Culbertson(Harvard University), Irina S. Moreira(University of Coimbra), Andréane Cartier(Boston Children's Hospital), Michel V. Levesque(Boston Children's Hospital), Asuka Inoue(Tohoku University), Nícia Rosário‐Ferreira(University of Coimbra), Maofu Liao(Harvard University), Sylvain Galvani(Boston Children's Hospital), Alec A. Schmaier(Beth Israel Deaconess Medical Center), Shihui Guo(Beth Israel Deaconess Medical Center)
Cited by 14
Related Papers
Prostaglandins and Inflammation
|Arteriosclerosis Thrombosis and Vascular Biology|2011|3.7k
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
|Pharmacological Reviews|2004|1.7k
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
|New England Journal of Medicine|2001|1.4k